Search Results - "Neau, D."

Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort by Bonnet, F, Le Marec, F, Leleux, O, Gerard, Y, Neau, D, Lazaro, E, Duffau, P, Caubet, O, Vandenhende, M A, Mercie, P, Cazanave, C, Dabis, F

“…The objective of the study was to describe the evolution of chronic non-AIDS related diseases and their risk factors, in patients living with HIV (PLHIV) in…”
Get full text

Clinical and biological features of enteroviral meningitis among adults and children and factors associated with severity and length of stay by Vareil, Mo, Wille, H., Kassab, S., Le-cornec, C., Puges, M., Desclaux, A., Lafon, M.E., Tumiotto, C., Cazanave, C., Neau, D.

“…•Clinical and biological features of Enterovirus meningitis are presented and compared in these papers in adults and children.•Managements of cases are…”
Get full text

Educational assessment of the first computerized national ranking exam in France in 2016: Opportunities for improvement by Rivière, E, Quinton, A, Neau, D, Constans, J, Vignes, J R, Dehail, P

“…In June 2016, 8124 medical students in their sixth year of graduation passed the first computerized national ranking exam (CNRE) in France after which they…”
Get full text

Experience of ultrasound performed by infectiologists, an innovating approach for the management of patients by Leitao, J., Martin, L., Desclaux, A., Dutronc, H., Neau, D., Dauchy, F.-A.

“…•There is a lack of data concerning the practice of ultrasound by infectious disease physicians.•Ultrasound performed by infectiologists is useful and…”
Get full text

Structure-Analysis of the HIV-1 Integrase Y143C/R Raltegravir Resistance Mutation in Association with the Secondary Mutation T97A by REIGADAS, S, MASQUELIER, B, CALMELS, C, LAGUERRE, M, LAZARO, E, VANDENHENDE, M, NEAU, D, FLEURY, H, ANDREOLA, M. L

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy by De Lédinghen, V., Barreiro, P., Foucher, J., Labarga, P., Castéra, L., Vispo, M. E., Bernard, P.-H., Martin-Carbonero, L., Neau, D., García-Gascó, P., Merrouche, W., Soriano, V.

“…The recent availability of non‐invasive tools to measure liver fibrosis has allowed examination of its extent and determination of predictors in all patients…”
Get full text

Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort by de Pommerol, M, Hessamfar, M, Lawson-Ayayi, S, Neau, D, Geffard, S, Farbos, S, Uwamaliya, B, Vandenhende, M-A, Pellegrin, J-L, Blancpain, S, Dabis, F, Morlat, P

“…The aim of the paper is to describe the characteristics of postmenopausal HIV-infected women and to investigate the factors associated with an earlier onset of…”
Get more information

Urolithiasis in HIV-Positive Patients Treated with Atazanavir by Couzigou, Carine, Daudon, Michel, Meynard, Jean Luc, Lebas, Françoise Borsa, Higueret, Denise, Escaut, Lélia, Zucman, David, Liotier, Jean-Yves, Quencez, Jean-Louis, Asselah, Karine, May, Thierry, Neau, Didier, Vittecoq, Daniel

“…Among protease inhibitors, atazanavir has not been associated with urolithiasis in clinical studies. We describe 11 cases of atazanavir-associated urolithiasis…”
Get full text

HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients by Salmon, D, Bani-Sadr, F, Gilbert, C, Rosenthal, E, Valantin, M.A, Simon, A, Neau, D, Morlat, P, Loko, M.A, Wittkop, L, Dabis, F

“…Highlights • SVR12 was 63% in a real-life setting in HIV/HCV patients treated with TVR or BOC. • Low HCV VL and virological response at W4 were the 2 factors…”
Get full text

Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004 by Larsen, C, Pialoux, G, Salmon, D, Antona, D, Le Strat, Y, Piroth, L, Pol, S, Rosenthal, E, Neau, D, Semaille, C, Delarocque Astagneau, E

“…Our objective was to estimate the prevalence of HCV and HBV co-infection among HIV-infected adults in France and describe the epidemiological characteristics…”
Get full text

Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients by Loko, M.-A., Bani-Sadr, F., Winnock, M., Lacombe, K., Carrieri, P., Neau, D., Morlat, P., Serfaty, L., Dabis, F., Salmon, D.

“…The impact of antiretroviral drug exposure and associated lipodystrophy and/or insulin resistance (IR) on advanced liver fibrosis in HIV/HCV‐coinfected…”
Get full text

Prevalence and factors associated with renal impairment in HIV‐infected patients, ANRS C03 Aquitaine Cohort, France by Déti, EK, Thiébaut, R, Bonnet, F, Lawson‐Ayayi, S, Dupon, M, Neau, D, Pellegrin, JL, Malvy, D, Tchamgoué, S, Dabis, F, Morlat, P

“…Objectives The aims of the present study were to estimate the prevalence of renal impairment (RI) among HIV‐infected adult patients and to investigate the…”
Get full text

LP20 : Safety and efficacy of all-oral daa regimens in HIV-HCV coinfected cirrhotic patients from the prospective ANRS CO13 - HEPAVIH cohort by Sogni, P, Gilbert, C, Lacombe, K, Piroth, L, Rosenthal, E, Dominguez, S, Chas, J, Neau, D, Poizot-Martin, I, Gervais Hasenknopf, A, Morlat, P, Simon, A, Zucman, D, Aumaitre, H, Lascoux-Combe, C, Esterle, L, Dabis, F, Wittkop, L, Salmon-Ceron, D

Get full text

Hepatitis C virus (HCV) protease variability and anti‐HCV protease inhibitor resistance in HIV/HCV‐coinfected patients by Trimoulet, P, Belzunce, C, Faure, M, Wittkop, L, Reigadas, S, Dupon, M, Ragnaud, J‐M, Fleury, H, Neau, D

“…Objectives Data on the natural selection of isolates harbouring mutations within the NS3 protease, conferring resistance to hepatitis C virus (HCV) protease…”
Get full text

Ledipasvir/Sofosbuvir in NS3/4A Protease Inhibitor-Experienced Subjects with HCV Genotype 1 and HIV-Co-Infection Final Results of the ANRS HC31 Softrih Study by Rosenthal, E, Fougerou-Leurent, C, Renault, A, Teicher, E, Dominguez, S, Naqvi, A, Metivier, S, Cotte, L, Reynes, J, Valantin, M.-A, Leroy, V, Pageaux, G.-P, Pol, S, Piroth, L, Perre, P, Morlat, P, Salmon-Ceron, D, Chas, J, Jeantils, V, de Truchis, P, Allègre, T, Dupon, M, Raffi, F, Yazdanpanah, Y, Poizot-Martin, I, Neau, D, Girard, P.-M, Zucman, D, Garraffo, R, Chevaliez, S, Carrieri, P, Aumaitre, H, Lacombe, K, Bailly, F, Billaud, E, Pailhé, A, Amri, I, Bourlière, M, Bellissant, E, Molina, J.-M

Get full text

Factors Associated with the Occurrence of AIDS-Related Non-Hodgkin Lymphoma in the Era of Highly Active Antiretroviral Therapy: Aquitaine Cohort, France by Bonnet, Fabrice, Balestre, Eric, Thiébaut, Rodolphe, Morlat, Philippe, Pellegrin, Jean-Luc, Neau, Didier, Dabis, François

“…Background. High grade non-Hodgkin lymphoma (NHL) remains the most common Acquired Immune Deficiency Syndrome (AIDS)—associated neoplasia and an important…”
Get full text

Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)‐coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort] by Michel, L, Lions, C, Winnock, M, Lang, J‐P, Loko, M‐A, Rosenthal, E, Marchou, B, Valantin, M‐A, Morlat, P, Roux, P, Sogni, P, Spire, B, Poizot‐Martin, I, Lacombe, K, Lascoux‐Combe, C, Duvivier, C, Neau, D, Dabis, F, Salmon‐Ceron, D, Carrieri, MP, Salmon, D., Benhamou, Y., Trimoulet, P., Izopet, J., Paradis, V., Carrieri, P., Katlama, C., Pialoux, G., Bonnard, P, Bicart See, A., Djebbar, R., Gervais, A., Goujard, C., Vittecoq, D., BaniSadr, F., Meyer, L., Boufassa, F., Dominguez, S., Autran, B., Roque, A. M., Solas, C., Fontaine, H., Serfaty, L., Chêne, G., Costagliola, D., Couffin‐Cadiergues, S.

“…Objectives The objective of this nested study was to assess the prevalence of psychiatric disorders in a sample of HIV/hepatitis C virus (HCV)‐coinfected…”
Get full text

Factors associated with guideline‐based hepatitis C virus (HCV) treatment initiation in HIV/HCV‐coinfected patients: role of comorbidities and physicians' perceptions by Winnock, M, Bani‐Sadr, F, Pambrun, E, Loko, M‐A, Carrieri, P, Neau, D, Morlat, P, Marchou, B, Dabis, F, Salmon, D

“…Objectives Many HIV‐infected patients with chronic hepatitis C virus (HCV) infection do not receive treatment for HCV infection, often because of…”
Get full text

Carotid intima–media thickness is slightly increased over time in HIV‐1‐infected patients by Mercié, P, Thiébaut, R, Aurillac‐Lavignolle, V, Pellegrin, JL, Yvorra‐Vives, MC, Cipriano, C, Neau, D, Morlat, P, Ragnaud, JM, Dupon, M, Bonnet, F, Lawson‐Ayayi, S, Malvy, D, Roudaut, R, Dabis, F

“…Objectives HIV‐infected patients are at risk of atherosclerosis and cardiovascular diseases. In a 12‐month follow‐up study, we aimed to investigate changes in…”
Get full text

Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Antibodies to Hepatitis B Core Antigen: Aquitaine Cohort, 2002–2003 by Neau, Didier, Winnock, Maria, Jouvencel, Anne-Christine, Faure, Murielle, Castéra, Laurent, Legrand, Elisabeth, Lacoste, Denis, Ragnaud, Jean-Marie, Dupon, Michel, Fleury, Hervé, Lafon, Marie-Edith, Dabis, François

“…We prospectively assessed the prevalence of occult hepatitis B virus (HBV) infection by investigating HBV replication in 160 human immunodeficiency virus…”
Get full text